Andy T. Long

Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19

Ulvan: A systematic review of extraction, composition and function

Maladaptive role of neutrophil extracellular traps in pathogen-induced lung injury

Macrophages in immunoregulation and therapeutics

Inflammation and tumor progression: signaling pathways and targeted intervention

Acute respiratory distress syndrome

Immunohaemostasis: a new view on haemostasis during sepsis

How to detect eosinophil ETosis (EETosis) and extracellular traps

Extracellular DNA traps in inflammation, injury and healing

In vivo evidence for extracellular DNA trap formation

Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue

Synthetic Siglec-9 Agonists Inhibit Neutrophil Activation Associated with COVID-19

Targeting neutrophil extracellular traps in severe acute pancreatitis treatment

Neutrophils and NETs in modulating acute and chronic inflammation

Haemostasis and innate immunity – a complementary relationship

Bioplastic made from seaweed polysaccharides with green production methods

Platelets as Central Actors in Thrombosis—Reprising an Old Role and Defining a New Character

COVID-19 and its implications for thrombosis and anticoagulation

Neutrophils: back in the thrombosis spotlight

Immunology of Acute and Chronic Wound Healing

Modulating neutrophil extracellular traps for wound healing

Host DNases prevent vascular occlusion by neutrophil extracellular traps

Neutralizing blood-borne polyphosphate in vivo provides safe thromboprotection

Contact system revisited: an interface between inflammation, coagulation, and innate immunity

Factor XII as a Therapeutic Target in Thromboembolic and Inflammatory Diseases

The factor XIIa blocking antibody 3F7: a safe anticoagulant with anti-inflammatory activities.